Andréia Cristina Conegero Sanches

Andréia Cristina Conegero Sanches

Auto-generated profile, based on publicly available information

Andréia Cristina Conegero Sanches

Centro de Ciências Médicas e Farmacêuticas, Universidade Estadual do Oeste do Paraná, Cascavel, Brazil

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2019 in Diagnostic Microbiology and Infectious Disease
Verified
Journal Article
Closed access
AOAna F. Oliota
Ana F. Oliota
SPSuelem T. Penteado
Suelem T. Penteado
FTFernanda Tonin
Fernanda Tonin
FFFernando Fernandez-Llimos
Fernando Fernandez-Llimos
ASAndreia C. Sanches
Andreia C. Sanches

14 February 2023 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
NGNaiara Gancedo
Naiara Gancedo
RIRaquel Isolani
Raquel Isolani
NONatalia Castelhano de Oliveira
Natalia Castelhano de Oliveira
CNCelso Vataru Nakamura
Celso Vataru Nakamura
DADaniela Cristina de Medeiros Araújo
Daniela Cristina de Medeiros Araújo
JMJoão Carlos Palazzo de Mello
João Carlos Palazzo de Mello
Limonium species represent a source of bioactive compounds that have been widely used in folk medicine. This study aimed to synthesize the anticancer and anti-proliferative potential of Limonium species through a systematic review. Searches were performed in the electronic databases PubMed/MEDLINE, Scopus, and Scielo and via a manual search. In vivo or in vitro studies that evaluated the anticancer or anti-proliferative effect of at least one Limonium species were included. In total, 942 studies were identified, with 33 articles read in full and 17 studies included for qualitative synthesis. Of these, 14 (82.35%) refer to in vitro assays, one (5.88%) was in vivo, and two (11.76%) were designed as in vitro and in vivo assays. Different extracts and isolated compounds from Limonium species were evaluated through cytotoxic analysis against various cancer cells lines (especially hepatocellular carcinoma—HepG2; n = 7, 41.18%). Limonium tetragonum was the most evaluated species. The possible cellular mechanism involved in the anticancer activity of some Limonium species included the inhibition of enzymatic activities and expression of matrix metalloproteinases (MMPs), which suggested anti-metastatic effects, anti-melanogenic activity, cell proliferation inhibition pathways, and antioxidant and immunomodulatory effects. The results reinforce the potential of Limonium species as a source for the discovery and development of new potential cytotoxic and anticancer agents. However, further studies and improvements in experimental designs are needed to better demonstrate the mechanism of action of all of these compounds.

3 April 2017 in Journal of Attention Disorders
Verified
Journal Article
Closed access
DODanielly Chierrito de Oliveira
Danielly Chierrito de Oliveira
PSPatricia Guerrero de Sousa
Patricia Guerrero de Sousa
CRCamila Borges dos Reis
Camila Borges dos Reis
FTFernanda Tonin
Fernanda Tonin
LSLaiza Maria Steimbach
Laiza Maria Steimbach
ASAndréia Cristina Conegero Sanches
Andréia Cristina Conegero Sanches
Objective: The aim of the study was to analyze evidence comparing the profile of drugs used to treat ADHD in adult patients. Method: Systematic searches were conducted in electronic databases. Randomized, double-blind, parallel controlled trials that evaluated the safety of drugs in ADHD were included. The statistical analyses were conducted by pairwise meta-analyses and mixed treatment comparison (MTC). Results: Ten (n = 3006) trials were included in the analyses. We observed statistical differences for the following outcomes: decreased appetite between atomoxetine and placebo (odds ratio [OR] = 0.15, 95% credibility interval [CrI] = [0.05, 0.38]) and extended-release mixed amphetamine salts and placebo (OR = 0.06, 95% CrI = [0.00, 0.51]); insomnia between atomoxetine and placebo (OR = 0.48, 95% CrI = [0.27, 0.88]) and extended-release mixed amphetamine salts and placebo (OR = 0.23, 95% CrI = [0.06, 0.76]); sleepiness between atomoxetine and methylphenidate OROS (OR = 0.24, 95% CrI = [0.06, 0.97]); and decreased libido between atomoxetine and placebo (OR = 0.28, 95% CrI = [0.08, 0.90]). Conclusion: It was possible to generate evidence about the safety profile of different ADHD drugs.

17 May 2023 in DARU Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
PDF file
LTLarissa Toigo
Larissa Toigo
ETEmilly Isabelli dos Santos Teodoro
Emilly Isabelli dos Santos Teodoro
AGAna Carolina Guidi
Ana Carolina Guidi
NGNaiara Cássia Gancedo
Naiara Cássia Gancedo
MPMarcus Vinícius Petruco
Marcus Vinícius Petruco
ASAndréia Cristina Conegero Sanches
Andréia Cristina Conegero Sanches
Objectives This scoping review aims to present flavonoid compounds' promising effects and possible mechanisms of action on potential therapeutic targets in the SARS-CoV-2 infection process. Methods A search of electronic databases such as PubMed and Scopus was carried out to evaluate the performance of substances from the flavonoid class at different stages of SARS-CoV-2 infection. Results The search strategy yielded 382 articles after the exclusion of duplicates. During the screening process, 265 records were deemed as irrelevant. At the end of the full-text appraisal, 37 studies were considered eligible for data extraction and qualitative synthesis. All the studies used virtual molecular docking models to verify the affinity of compounds from the flavonoid class with crucial proteins in the replication cycle of the SARS-CoV-2 virus (Spike protein, PLpro, 3CLpro/ MPro, RdRP, and inhibition of the host's ACE II receptor). The flavonoids with more targets and lowest binding energies were: orientin, quercetin, epigallocatechin, narcissoside, silymarin, neohesperidin, delphinidin-3,5-diglucoside, and delphinidin-3-sambubioside-5-glucoside. Conclusion These studies allow us to provide a basis for in vitro and in vivo assays to assist in developing drugs for the treatment and prevention of COVID-19. Graphical abstract

2 March 2021 in Research, Society and Development
Verified
Journal Article
Open access
PDF file
FFFabiana Sari Ferreira
Fabiana Sari Ferreira
TPThais Arnoni Pereira
Thais Arnoni Pereira
BSBeatriz Paludo de Souza
Beatriz Paludo de Souza
ASAndréia Cristina Conegero Sanches
Andréia Cristina Conegero Sanches
Visando a promoção de práticas seguras e a geração de indicadores para o monitoramento e avaliação do processo da utilização dos medicamentos, o objetivo deste trabalho foi identificar os erros de prescrição e dispensação evitados pela equipe farmacêutica a fim de contribuir para a qualidade do serviço. Trata-se de uma análise transversal realizada na farmácia central em um hospital escola no período de 01 janeiro a 31 dezembro de 2019. Foram avaliados os registros de intervenções farmacêuticas e da conferência das medicações antes da dispensação. Os dados coletados produziram indicadores que foram analisados através do Diagrama de Pareto e confrontados com os eventos notificados na instituição. Os erros de prescrição mais detectados pela intervenção farmacêutica foram a frequência e a dose inadequada. Os erros prevenidos durante a conferência dos pacotes de medicações foram a falta de medicamento prescrito e troca de horário. Além disso, das notificações relacionadas aos erros de medicação, foram observados que 32,88% eram referentes aos erros de prescrição, 41,10% aos erros de dispensação e 26,03% aos erros de administração. Mesmo com a subnotificação, foram registrados 3343 eventos prevenidos pela equipe farmacêutica, mostrando que sua atuação é indispensável e faz parte das estratégias de prevenção de eventos adversos no âmbito hospitalar.

1 December 2023 in Cuadernos de Educación y Desarrollo
Verified
Journal Article
Open access
PDF file
MBMarina Barbara Marin Barzotto
Marina Barbara Marin Barzotto
MGMyllena Mazzo de Queiroga Gonçalves
Myllena Mazzo de Queiroga Gonçalves
FBFernanda Giacomini Bueno
Fernanda Giacomini Bueno
SVSuzane Virtuoso
Suzane Virtuoso
ASAndreia Cristina Conegero Sanches
Andreia Cristina Conegero Sanches
O Transtorno do Espectro Autista é um distúrbio do neurodesenvolvimento que tem como principal característica a limitação da comunicação social pelo indivíduo acometido. Para o tratamento dos sintomas irritabilidade do TEA, são aprovados apenas os fármacos risperidona e aripiprazol. Os objetivos deste estudo são juntar evidências de estudos clínicos randomizados sobre outros possíveis tratamentos farmacológicos, e visualizar quais os desfechos que esses medicamentos trazem para o indivíduo através de uma revisão sistemática seguindo as recomendações Cochrane e PRISMA. Dos artigos selecionados, 33 artigos foram lidos na íntegra, contendo 15 fármacos como intervenção farmacológica. Destes, 3 artigos envolvendo aripiprazol versus placebo foram selecionados para a metanalise, que mostrou resultados significativos para os pacientes, principalmente para a escala da hiperatividade, CGI-Irritabilidade e CGI-Severidade. No entanto, o estudo mostrou que o aripiprazol quando comparado ao placebo apresenta como efeito adverso o ganho de peso. A grande parte dos medicamentos encontrados possuem efeitos benéficos para os sintomas do TEA, porém devido à falta de resultados quantificáveis e mensuráveis, e a ampla quantidade de escalas utilizadas nos estudos, não foi possível realizar as metanalises com todos os medicamentos.